drugset / Trial / NCT00231790
A Placebo-Controlled Study of MK0634 in Patients With Overactive Bladder (0634-007)
RandomizedParallel-groupDouble-blindTreatment
Summary
Overactive bladder is very prevalent in postmenopausal women. The current study is designed to investigate whether a new drug may offer safe and effective treatment.
Timeline
- Start
- 2005-08
- Primary completion
- 2006-09
- Completion
- 2006-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | MK-0634 | Unknown | 50 mg | Oral |
| Subject | MK-0634 | Unknown | 125 mg | Oral |
| Subject | MK-0634 | Unknown | 375 mg | Oral |